CM

Claire Marie Ogrady

Director Director DIN 07330960
DIN 07330960 First appointment Nov 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Nov 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Claire Marie Ogrady

Data last updated:

Claire Marie Ogrady has 10 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07330960
Primary Designation Director
First Appointment 06 Nov 2015
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Astrazeneca Pharma India Limited L24231KA1979PLC003563
Director Appointed In Casual Vacancy06 Nov 20151979₹1,757 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Astrazeneca Pharma India Limited
Premium access

Shareholding and investment profile for Claire Marie Ogrady

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Claire Marie Ogrady

Claire Marie Ogrady has 10 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

Claire Marie Ogrady has expertise in General Business.

Claire Marie Ogrady has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available